Advertisement

Topics

Paroxysmal supraventricular tachycardia (PSVT) - Biotech, Pharma and Life Science Channel

14:24 EST 20th January 2019 | BioPortfolio

Paroxysmal supraventricular tachycardia (PSVT) is episodes of rapid heart rate that start in a part of the heart above the ventricles. "Paroxysmal" means from time to time.

The heart will suddenly start racing, then stop or slow down abruptly.  Episodes can last for seconds, minutes, hours or (in rare cases) days. They may occur regularly, several times a day, or very infrequently, once or twice a year.  The heart rate may be as high as 250 beats per minute, but is usually between 140 and 180 (a normal heartbeat should be 60-100 beats per minute at rest).

SVT is caused by abnormal electrical impulses that start suddenly in the upper chambers of your heart (the atria). These impulses override your heart's natural rhythm.  It is often a short circuit in the electrical system of your heart that causes these spontaneous impulses. The short circuit causes an electrical signal to travel continuously around in a circle. Each time the signal completes the circuit, the impulse spreads out to the rest of your heart, forcing it to beat rapidly.  SVT attacks often happen for no obvious reason. However, they may be triggered by a change in posture, exertion, emotional upset, coffee or alcohol.

Source: http://www.nhs.uk/conditions/Supraventricular-tachycardia/Pages/Introduction.aspx

View research papers on diagnosiscauses and treatment.

PubMed Articles [281 Associated PubMed Articles listed on BioPortfolio]

Physical Therapy Management of Adults with Mild Traumatic Brain Injury.

Rehabilitation for individuals after mild traumatic brain injury (mTBI) or concussion requires emphasis on both cognitive and physical rest, with a gradual return to activity including sports. As the ...

Aripiprazole overdose and transient 2:1 second degree atrioventricular block: only a coincidence?

Atypical antipsychotics, unlike traditional antipsychotics, are considered to have limited cardiovascular side effects, but recent evidence drew attention to potential cardiac rhythm disturbances duri...

Early repolarization pattern as a predictor of atrial fibrillation recurrence following radiofrequency pulmonary vein isolation.

Early repolarization patterns (ERP) have been found to be associated with poor cardiovascular end points. We aimed to evaluate the ERP prevalence among patients with structurally normal hearts undergo...

Dabigatran causing severe acute kidney injury in a patient with liver cirrhosis.

Anticoagulant-related nephropathy (ARN), a significant but frequently undiagnosed problem in patients receiving anticoagulation, is found to be associated with increased renal morbidity and all-cause ...

Catecholaminergic Polymorphic Ventricular Tachycardia: The Cardiac Arrest Where Epinephrine Is Contraindicated.

To raise awareness among pediatric intensive care specialists of catecholaminergic polymorphic ventricular tachycardia; an uncommon cause of polymorphic ventricular tachycardia and ventricular fibrill...

Whole-Exome Sequencing Identifies a Novel Mutation (p.L320R) of Alpha-Actinin 2 in a Chinese Family with Dilated Cardiomyopathy and Ventricular Tachycardia.

Dilated cardiomyopathy (DCM) is a severe cardiovascular disease which can lead to heart failure and sudden cardiac death (SCD). The typical feature of DCM is left ventricular enlargement or dilatation...

Evaluation of Wearable Digital Devices in a Phase I Clinical Trial.

We assessed the performance of two US Food and Drug Administration (FDA) 510(k)-cleared wearable digital devices and the operational feasibility of deploying them to augment data collection in a 10-da...

Automated Source Estimation of Scalp EEG Epileptic Activity Using eLORETA Kurtosis Analysis.

eLORETA (exact low-resolution brain electromagnetic tomography) is a technique created by Pascual-Marqui et al. [Int J Psychophysiol. 1994 Oct; 18(1): 49-65] for the 3-dimensional representation of cu...

Radiofrequency ablation of right ventricular tachycardia in patients with no femoral access: safety and efficacy of a superior approach.

Ventricular tachycardia (VT) ablation has been proven to be effective and safe to avoid arrhythmia recurrences in patients with repaired congenital heart disease (CHD). However, some of these patients...

Legally Lethal Kratom: A Herbal Supplement with Overdose Potential.

This case report describes an overdose on kratom, and elicits the potential dangers of overdose on the regulated dietary supplement. A young male presented to the emergency department intubated after ...

News Articles [82 Associated News Articles listed on BioPortfolio]

The Assistance Fund Announces New Financial Assistance Program for Individuals with Paroxysmal Nocturnal Hemoglobinuria

The Assistance Fund, an independent charitable patient assistance foundation that helps patients and families facing high out-of-pocket medical costs, today announced the launch o...

Alexion's rare blood disease injection wins FDA approval

The FDA has approved Alexion's Ultomiris, or ravulizumab, injection as a treatment for adult patients with paroxysmal nocturn -More- 

FDA Approves Ravulizumab for Paroxysmal Nocturnal Hemoglobinuria

The FDA has approved ravulizumab-cwvz as an injection treatment of adult patients with paroxysmal nocturnal hemoglobinuria, a rare blood disorder that leads to hemolysis.

Alexion Receives Early FDA Approval for Ultomiris in Adults with Paroxysmal Nocturnal Hemoglobinuria

BOSTON–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the U.S. Food and Drug Administration (FDA) has approved ULTOMIRIS™ (ravulizumab-cwvz), the f...

FDA Approves New Treatment for Rare, Life-Threatening Blood Disease

NewsAlexion receives early FDA approval for Ultomiris (Ravulizumab-cwvz) in adults with paroxysmal nocturnal hemoglobinuria.

Ravulizumab for adult patients with rare blood disease gains FDA approval

The FDA approved Alexion's Ultomiris, or ravulizumab, indicated to treat adults with the rare blood disease paroxysmal noctur -More- 

Alexion Pharma Announces FDA Approval Of ULTOMIRIS

WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals, Inc. (ALXN), on Friday, announced the U.S. FDA approved ULTOMIRIS for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria, an u...

New treatment for adults with rare, life-threatening blood disease receives FDA approval

The U.S. Food and Drug Administration today approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening b...

FDA approves Alexion's Ultomiris for paroxysmal nocturnal haemoglobinuria https://firstwordpharma.com/node/1613200?tsid=33 …

FDA approves Alexion's Ultomiris for paroxysmal nocturnal haemoglobinuria https://firstwordpharma.com/node/1613200?tsid=33 …

FDA Approves Ultomiris (ravulizumab-cwvz) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)

BOSTON--(BUSINESS WIRE)-- December 21, 2018 -- Alexion Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Ultomiris (ravulizumab-cwvz), the first and o...

Companies [5 Associated Companies listed on BioPortfolio]

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed ...

Alexion Pharmaceuticals Incorporated

Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rar...

Topera, Inc.

Topera Medical (Topera, Inc.) is developing the proprietary FIRMap® System to assist electrophysiologists in the identification of the electrical source of cardiac arrhythmias....

Acutus Medical and Index Ventures

Acutus Medical is a medical technology company committed to developing an innovative breakthrough platform technology of safe, cost effective and clinically advanced tools for the...

Topera Medical

Topera Medical (Topera, Inc.) is developing the proprietary FIRMap® System to assist electrophysiologists in the identification of the electrical source of cardiac arrhythmias....

Clinical Trials [466 Associated Clinical Trials listed on BioPortfolio]

Clinical Implication of the Tunable Crack Sensor

[Development of diagnosis algorism for paroxysmal arrhythmia using ultra-thin resistive membrane: a pilot study] Comparison of blood pressure via tunable crack sensor and invasive pressure...

Comparison of Osteocentral Versus Locoregional Anesthesia in Case of Mandibular Molar Pulpitis

The irreversible acute pulpitis is the most common emergency at the hospital during dental consultation. Pulpitis are characterized by intense and spontaneous oro-facial pains. In case of ...

(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes

Androgen Deprivation Therapy (ADT) is a critical component of advanced prostate cancer treatment but causes numerous adverse effects including decreased bone mass, decreased muscle mass, g...

The Thrombotic Potential of Heart Chambers in the Presence or Absence of Atrial Fibrillation.

The investigators aim to test the thrombotic potential of various heart chambers including left atrium, left atrial appendage, right atrium and peripheral veins. Blood samples will be take...

Left Atrial Appendage Closure in Combination With Catheter Ablation

This study is a prospective cohort study aimed at investigating the efficacy and safety of left atrial appendage closure in combination with catheter ablation in patients with atrial fibri...

R Wave Sensing After VT Ablation

Sustained, monomorphic ventricular tachycardia (VT) is most commonly encountered in patients with structural heart disease, usually with ischemic aetiology. It has been proven that repeate...

Atrial Fibrillation Ablation: Radiofrequency or Cryoablation?

The study aims to compare 3 techniques routinely used for paroxysmal atrial fibrillation ablation: radiofrequency catheter ablation without contact-force, radiofrequency catheter ablation ...

Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke

The goal of this research study is to develop a smartphone application capable of monitoring paroxysmal atrial fibrillation (pAF) in people who have survived a stroke or transient ischemic...

Individualized Approach vs. Fixed Approach

The purpose of the current study is to assess differences regarding the acute efficacy, safety, procedural duration, radiation exposure and long-term success of the novel AFA-Pro in combin...

Hybrid Therapy and Heart Team for Atrial Fibrillation

Atrial fibrillation (AF) is the most common cardiac arrhythmia with a prevalence ranging from 5% over 60 years old to 17% after 85 years old. Besides hemodynamical compromises and occurren...

Medical and Biotech [MESH] Definitions

A generic expression for any tachycardia that originates above the BUNDLE OF HIS.

A rare form of supraventricular tachycardia caused by automatic, not reentrant, conduction initiated from sites at the atrioventricular junction, but not the ATRIOVENTRICULAR NODE. It usually occurs during myocardial infarction, after heart surgery, or in digitalis intoxication with a HEART RATE ranging from 140 to 250 beats per minute.

Abnormally rapid heartbeats with sudden onset and cessation.

An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...